DC Funds, LP

Institutional

CIK 0001869028

$1.5M

Reported AUM

Positions

Q1 2026

Period

2026-05-14

Filed

The Brief · DC Funds, LP · Q1 2026

AI · grounded in 13F

DC Funds, LP reported no changes to its 13F holdings for 2026-03-31 relative to 2025-12-31.

Portfolio · Q1 2026

Top holdings

#	Stock	Issuer	Price	Day %	1Y Gr.	5Y Gr.	Value	% of book	Δ shares (QoQ)	Status
1	TCRX	TSCAN THERAPEUTICS INC	$0.74	-4.13%	-54.22%	-91.66%	$630K	42.40%	—	HELD
2	HOWL	WEREWOLF THERAPEUTICS INC	$0.46	2.45%	-60.34%	-97.42%	$490K	33.01%	—	HELD
3	BRNS	BARINTHUS BIOTHERAPEUTICS PL	$0.57	0.70%	-59.02%	-96.21%	$365K	24.59%	—	HELD

Source: SEC EDGAR · accession 0001398344-26-009112. 13F discloses long positions only — shorts, foreign equities, and options are excluded.